A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma

RECRUITING

University Hospital of Lausanne (CHUV), Lausanne

RECRUITING

University Hospitals of Geneva (HUG), Geneva

RECRUITING

University Hospital of Bern (Inselspital), Bern

RECRUITING

NYU Langone Health, New York

RECRUITING

Hospital Universitario Reina Sofia, Córdoba

RECRUITING

Virginia Cancer Specialists, Fairfax

RECRUITING

Asklepios Clinic Altona, Hamburg

RECRUITING

Hospital General Universitario Gregorio Maranon (HGUGM), Madrid

RECRUITING

South Texas Accelerated Research Therapeutics (START) - Madrid - Hospital Universitario Fundacion Jimenez Diaz Location, Madrid

RECRUITING

The START Center for Cancer Care - Madrid - CIOCC - Hospital Universitario Madrid Sanchinarro Location, Madrid

RECRUITING

Orlando Health, Orlando

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

RECRUITING

Karmanos Cancer Institute, Detroit

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

RECRUITING

START - South Texas Accelerated Research Therapeutics, San Antonio

RECRUITING

University of Colorado Hospital, Aurora

RECRUITING

USC/Norris Comprehensive Center, Los Angeles

RECRUITING

University of California Los Angeles (UCLA), Los Angeles

RECRUITING

Virginia Mason Medical Center, Seattle

RECRUITING

University of Florida, Gainesville